Allouche Cyril 4
4 · Revance Therapeutics, Inc. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Award
Common Stock
2019-01-24+3,150→ 7,150 total - Award
Employee Stock Option (Right to Buy)
2019-01-24+6,500→ 6,500 totalExercise: $17.23Exp: 2029-01-23→ Common Stock (6,500 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Mr. Allouche's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 24, 2019, subject to Mr. Allouche's Continuous Service (as defined in the Plan) on each vesting date.